V. Buckalew

发表

Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation.

G. Eknoyan, V. D’Agati, J. Winchester, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renin response and angiotensinogen control during graded hemorrhage and shock in the dog.

H. E. Schmid, V. Buckalew, O. Beaty, 1976, The American journal of physiology.

Analgesic use and chronic renal disease.

C. Weinberg, V. Buckalew, D. Sandler, 1989, The New England journal of medicine.

Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. II. Nephrotoxins of significant frequency and economic impact.

G. Eknoyan, V. Buckalew, M. D. de Broe, 1997, Renal failure.

Fenoldopam, a dopamine agonist, for hypertensive emergency: a multicenter randomized trial. Fenoldopam Study Group.

S. Oparil, R. Luther, V. Buckalew, 2008, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Racial differences in HLA antigen frequency and hypertensive renal failure.

M. Espeland, B. Freedman, V. Buckalew, 1991, American journal of hypertension.

Role of nitric oxide in the evolution of renal ischemia in two-kidney, one-clip renovascular hypertension.

V. Buckalew, H. Suzuki, C. Ferrario, 1998, Hypertension research : official journal of the Japanese Society of Hypertension.

Final outcome results of the Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS). A randomized controlled trial.

M. Rocco, N. Borhani, M. Bond, 1996, JAMA.

Endogenous Digitalis-Like Factors: An Overview of the History

V. Buckalew, 2015, Front. Endocrinol..

Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: Results from a 10-week, double-blind, placebo-controlled, dose-titration study

V. Buckalew, Michael A. Weber, J. Neutel, 1999 .

Plasma volume in resistant hypertension: guide to pathophysiology and therapy.

J. Graves, V. Buckalew, R. Bloomfield, 1989, The American journal of the medical sciences.

Sodium, water, and congestive heart failure.

V. Buckalew, R. Hamilton, 1984, Annals of internal medicine.

Free water reabsorption during solute diuresis in normal and potassium-depleted rats.

V. Buckalew, M. Goldberg, M. Ramirez, 1967, The American journal of physiology.

Characterization of a competitive and reversible ligand to E2 conformation of Na, K ATPase molecule.

V. Buckalew, A. L. Rauch, 1988, Biochemical and biophysical research communications.

Circulating digitalis-like factors

V. Buckalew, 1988, Pediatric Nephrology.

Preoptic-hypothalamic periventricular lesions reduce natriuresis to volume expansion.

M. Brody, V. Buckalew, G. Fink, 1983, The American journal of physiology.

Differential Effect of Dietary Salt on Renal Growth in Dahl Salt‐Sensitive and Salt‐Resistant Rats

V. Buckalew, A. L. Rauch, C. McCormick, 1989, Hypertension.

Natriuretic hormone: current status.

V. Buckalew, C. Paschal-McCormick, 1989, American journal of nephrology.

Plasma volume expansion increases lysophosphatidylcholine and digitalis-like activity in rat plasma.

V. Buckalew, A. L. Rauch, 1988, Life sciences.

Endogenous digitalis-like substance in plasma of volume-expanded dogs

V. Buckalew, K. Gruber, J. M. Whitaker, 1980, Nature.

A digoxin-like immunoreactive substance in preeclampsia.

J. F. Hennessy, V. Buckalew, J. P. Gusdon, 1984, American journal of obstetrics and gynecology.

Complete distal renal tubular acidosis in systemic lupus: clinical and laboratory findings.

R. Caruana, V. Buckalew, C. Barish, 1985, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Mechanism of exaggerated natriuresis in hypertensive man: impaired sodium transport in the loop of Henle.

V. Buckalew, J. Puschett, M. Goldberg, 1969, The Journal of clinical investigation.

Vasorelaxant effect of C16-PAF and C18-PAF on renal blood flow and systemic blood pressure in the anesthetized rat.

V. Buckalew, J. Strandhoy, R. Handa, 1991, Life sciences.

Renal manifestations of sickle cell disease.

V. Buckalew, A. Someren, 1974, Archives of internal medicine.

Incomplete renal tubular acidosis. Physiologic studies in three patients with a defect in lowering urine pH.

V. Buckalew, G. Ludwig, L. Chaykin, 1968, The American journal of medicine.

Endogenous digitalis-like factors. An historical overview.

V. Buckalew, 2005, Frontiers in bioscience : a journal and virtual library.

Eplerenone reduces proteinuria in type II diabetes mellitus: implications for aldosterone involvement in the pathogenesis of renal dysfunction

V. Buckalew, M. Epstein, B. Roniker, 2002 .

Hereditary renal tubular acidosis. Report of a 64 member kindred with variable clinical expression including idiopathic hypercalciuria.

V. Buckalew, D. Rudman, M. Shulman, 1974, Medicine.

Candidate gene analysis in African Americans with renal failure.

B. Freedman, V. Buckalew, 1999, Renal failure.

OR-54: Antiproteinuric efficacy of eplerenone, enalapril, and eplerenone/enalapril combination therapy in diabetic hypertensives with microalbuminuria

V. Buckalew, M. Epstein, B. Roniker, 2002 .

The incidence of diuretic-induced hypokalemia in two distinct clinic settings.

V. Buckalew, D. Wilson, R. Bloomfield, 1986, Journal of clinical hypertension.

Sickle-cell nephropathy.

V. Buckalew, 1970, Annals of internal medicine.

Editorial: Natriuretic Hormones

V. Buckalew, H. Gonick, 2015, Front. Endocrinol..

Ion transport characteristics in rhesus monkey erythrocytes: relationship to age and blood pressure.

J. F. Hennessy, V. Buckalew, K. Gruber, 1984, Clinical and experimental hypertension. Part A, Theory and practice.

Salt, natriuretic hormone, and hypertension.

V. Buckalew, 1981, Annals of internal medicine.

Elevated endoxin-like factor complicating a multifetal second trimester pregnancy: treatment with digoxin-binding immunoglobulin.

V. Buckalew, C. Adair, J. Ernest, 1996, American journal of nephrology.

The effect of dialysates and ultrafiltrates of plasma of saline-loaded dogs on toad bladder sodium transport.

V. Buckalew, F. Martinez, W. Green, 1970, The Journal of clinical investigation.

The association of a humoral sodium transport inhibitory activity with renal escape from chronic mineralocorticoid administration in the dog.

V. Buckalew, C. Lancaster, 1972, Clinical science.

Further Characterization and Evidence for a Precursor in the Formation of Plasma Antinatriferic Factor

V. Buckalew, K. Gruber, 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

GAMMA–2 MSH IS NATRIURETIC IN THE RAT

J. Harris, V. Buckalew, K. Gruber, 1985 .

Habitual use of acetaminophen as a risk factor for chronic renal failure: a comparison with phenacetin.

V. Buckalew, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Studies of a Humoral Sodium Transport Inhibitory Activity in Normal Dogs and Dogs with Ligation of the Inferior Vena Cava

V. Buckalew, C. Lancaster, VARDAMAN M. BUCKALEW, 1971, Circulation research.

A tribute to Hugh de Wardener.

V. Buckalew, H. Gonick, H. Kramer, 2014, Hypertension.

The hemodynamic effects of intravenous digoxin-binding fab immunoglobulin in severe preeclampsia: a double-blind, randomized, clinical trial

V. Buckalew, C. Adair, J. Rose, 2009, Journal of Perinatology.

Natriuretic and hypertensive activities reside in a fragment of ACTH.

P. Hutchins, V. Buckalew, K. Gruber, 1984, Hypertension.

Analgesic-associated nephropathy and transitional cell carcinoma of the urinary tract.

H. M. Schey, V. Buckalew, W. Corbett, 1980, Annals of internal medicine.

Natriuretic and sodium transport inhibitory activity in plasma of volume-expanded dogs.

V. Buckalew, D. Nelson, David B. Nelson, 1974, Kidney international.

Chronic renal failure and end-stage renal disease in northwest North Carolina. Importance of analgesic-associated nephropathy.

V. Buckalew, T. Gonwa, R. Hamilton, 1981, Archives of internal medicine.

Atrial peptides modify the effect of marinobufagenin on sodium pumps: implications for blood pressure control.

V. Buckalew, 2006, Hypertension.

Is Preeclampsia a Pro-fibrotic Condition?

V. Buckalew, 2020, American journal of hypertension.

Digoxin Immune Fab Treatment for Severe Preeclampsia

J. A. Johnston, G. Saade, V. Buckalew, 2010, American journal of perinatology.

Tissue distribution of an endogenous ligand to the Na, K ATPase molecule.

V. Buckalew, A. L. Rauch, 1988, Biochemical and biophysical research communications.

Effect of lysophosphatidylcholine on renal hemodynamics and excretory function in anesthetized rats.

V. Buckalew, R. K. Handa, 1992, Life sciences.

The Syndrome of Distal (Type 1) Renal Tubular Acidosis: CLINICAL AND LABORATORY FINDINGS IN 58 CASES

V. Buckalew, 1988, Medicine.

Effects of Fab digoxin-specific antibody(Fab) on mean arterial pressure (MAP) in severe preeclampsia(PE)

A. Hinshaw, V. Buckalew, J. Rose, 1997 .

Recurrence of anti-glomerular basement membrane antibody mediated glomerulonephritis in an isograft.

V. Buckalew, C. Wilson, P. Hirszel, 1981, Clinical immunology and immunopathology.

Is endogenous ouabain a physiological regulator of cardiovascular and renal function?

V. Buckalew, 2009, American journal of physiology. Heart and circulatory physiology.

Antagonism of the hydrosmotic effect of vasopressin by the antihypertensive, guanabenz.

V. Buckalew, J. Strandhoy, B. Steg, 1980, Life Science.

Effect of vasopressin on sodium excretion and plasma antinatriferic activity in the dog.

V. Buckalew, K. A. Dimond, 1976, The American journal of physiology.

Nephrolithiasis in renal tubular acidosis.

V. Buckalew, V M Buckalew, 1989, The Journal of urology.

Prevention of Renal Failure

V. Buckalew, J. Burkart, R. Hamilton, 1989 .

Atrial natriuretic factor.

V. Buckalew, R. Hamilton, M. Morris, 1987, Advances in internal medicine.

Analgesic nephropathy: a significant cause of morbidity in the United States.

H. M. Schey, V. Buckalew, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: a secondary analysis of the DEEP Trial.

G. Saade, V. Buckalew, S. Graves, 2013, American journal of obstetrics and gynecology.

Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: report of the national analgesic nephropathy study.

S. Shapiro, P. Kimmel, L. Cupples, 2006, Journal of the American Society of Nephrology : JASN.

Renal Disease from Habitual Antipyretic Analgesic Consumption: An Assessment of the Epidemilogic Evidence

H. M. Schey, V. Buckalew, 1986, Medicine.

Role of endogenous digitalis-like factors in the clinical manifestations of severe preeclampsia: a sytematic review.

V. Buckalew, 2018, Clinical science.

Effects of increased sodium delivery on distal tubular sodium reabsorption with and without volume expansion in man.

V. Buckalew, J. Puschett, B. Walker, 1970, The Journal of clinical investigation.

Regulation of plasma atrial natriuretic peptide by the central nervous system.

V. Buckalew, M. Callahan, M. Morris, 1990, The American journal of physiology.

Effects of phospholipids on renal function.

V. Buckalew, J. Strandhoy, R. K. Handa, 1993, Journal of cardiovascular pharmacology.

Selective inhibition of vasoconstrictor responses by platelet-activating factor in rat kidney.

V. Buckalew, J. Strandhoy, R. K. Handa, 1991, The American journal of physiology.

CLCN5 mutation Ser244Leu is associated with X-linked renal failure without X-linked recessive hypophosphatemic rickets.

J. Seidman, C. Seidman, V. Buckalew, 1998, Kidney international.

Capillary electrophoresis for the determination of glomerular filtration rate using nonradioactive iohexol.

M. Rocco, V. Buckalew, L. Moore, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Measurement of glomerular filtration rate using nonradioactive Iohexol: comparison of two one-compartment models.

M. Rocco, V. Buckalew, L. Moore, 1996, American Journal of Nephrology.

Techniques of renal biopsy.

V. Buckalew, R. D. Almkuist, 1979, Urologic clinics of North America.

Renal Tubular Dysfunction

V. Buckalew, M. Moore, F. X. Fellers, 1967, Pediatrics.

The familial risk of end-stage renal disease in African Americans.

B. Freedman, V. Buckalew, B. Spray, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal ar and a2‐Adrenoceptor Mediated Vasoconstriction in Dogs: Comparison of Phenylephrine, Clonidine, and Guanabenz

V. Buckalew, J. Strandhoy, D. Wolff, 1984, Journal of cardiovascular pharmacology.

Synergistic effect of modest volume expansion on the diuretic and natriuretic action of guanabenz.

V. Buckalew, J. Strandhoy, M. Morris, 1983, The Journal of pharmacology and experimental therapeutics.

Renal effects of the antihypertensive, guanabenz, in the dog.

V. Buckalew, J. Strandhoy, M. Morris, 1982, The Journal of pharmacology and experimental therapeutics.

Analgesic nephropathy and urinary-tract carcinoma.

V. Buckalew, W. Corbett, T. Gonwa, 1979, Annals of internal medicine.

Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group.

R. Berg, V. Buckalew, G. Schulman, 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Evidence for a vascular sensitizing factor in plasma of saline-loaded dogs.

P. Hutchins, V. Buckalew, K. Gruber, 1982, Hypertension.

Reappraisal of the impact of race on survival in patients on dialysis.

B. Freedman, V. Buckalew, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Effects of race on albuminuria and risk of cardiovascular and kidney disease

B. Freedman, V. Buckalew, 2011, Expert review of cardiovascular therapy.

Renal biopsy findings in presumed hypertensive nephrosclerosis.

B. Freedman, V. Buckalew, J. Burkart, 1994, American journal of nephrology.

Column Chromatography of Plasma Antinatriferic Activity

V. Buckalew, 1978 .

Variable factors affecting ultrafiltration of a humoral sodium transport inhibitor.

V. Buckalew, 1972, Nephron.

The Syndrome of Distal (Type 1) Renal Tubular Acidosis. Clinical and Laboratory Findings in 58 Cases

V. Buckalew, Caruana Rj, 1989 .

Erythrocyte sodium/potassium ATPase activity in severe preeclampsia

V. Buckalew, C. Adair, G. T. Haupert, 2009, Journal of Perinatology.

Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group.

A. Levey, T. Greene, V. Buckalew, 1997, Hypertension.

Cardiovascular tissue phospholipid metabolism in the Dahl rat: influence of dietary salt.

J. F. Hennessy, V. Buckalew, A. L. Rauch, 1987, Clinical and experimental hypertension. Part A, Theory and practice.

The Multicenter Isradipine Diuretic Atherosclerosis Study (MIDAS)-Reply

M. Rocco, M. Bond, M. Mercuri, 1997 .

Effects of race on albuminuria and risk of cardiovascular and kidney disease

B. Freedman, V. Buckalew, 2011, Expert review of cardiovascular therapy.

Role of endogenous digitalis-like factors in the clinical manifestations of severe preeclampsia: a sytematic review.

V. Buckalew, 2018, Clinical science.

The Multicenter Isradipine/Diuretic Atherosclerosis Study: A Study of the Antiatherogenic Properties of Isradipine in Hypertensive Patients

N. Borhani, M. Bond, J. Sowers, 1991, Journal of Cardiovascular Pharmacology.

Endocrinologic Effects of Antihypertensive Therapy with Guanabenz or Hydrochlorothiazide

V. Buckalew, J. Strandhoy, J. Eldridge, 1984, Journal of cardiovascular pharmacology.

Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.

M. Weber, V. Buckalew, J. Neutel, 1999, American heart journal.

Erythrocyte sodium concentration and 86Rb uptake in weanling Dahl rats.

J. F. Hennessy, V. Buckalew, A. L. Rauch, 1989, American journal of hypertension.